Figure 2From: Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model Modeling age-compartments and vaccine efficacy periods. Vaccine efficacy was modeled in three phases: initial ramp-up efficacy (2–13 months), full efficacy (13 months-3 years) and waning efficacy (3–10 years).Back to article page